Oxford PharmaGenesis, Inc. has been certified a ‘Great Place to Work’ by a leading global authority on high-performing workplace cultures. In an anonymized survey conducted by the Great Place to Work group, 92% of employees at Oxford PharmaGenesis Inc. said that the company was a great workplace (further information). The award caps a record year for the US office, which has recently seen the company expand into new offices in the Philadelphia area.
“I’m very proud of the achievements of our amazing US team. This is truly an organization of high-performing, dedicated and clever individuals who excel in the art and science of medical communications,” says Brian Falcone, Executive Vice President, Oxford PharmaGenesis, Inc.
“We’ve been able to identify this sweet spot where we can still accomplish the tasks put before us while maintaining a healthy, sustainable and rewarding work environment. I very much look forward to watching this office and these individuals grow into the powerhouses of medical communications they are destined to be.”
“We applaud Oxford PharmaGenesis, Inc. for seeking certification and releasing its employees’ feedback,” said Kim Peters, Executive Vice President of Great Place to Work’s Certification Program. “These ratings measure [a company’s] capacity to earn its own employees’ trust and create a great workplace – critical metrics that anyone considering working for, or doing business with, Oxford PharmaGenesis, Inc. should take into account as an indicator of high performance.”
Founded in 1998, Oxford PharmaGenesis is a global, independently owned HealthScience communications consultancy, providing high-quality scientific writing and strategic consultancy services to the pharmaceutical, medical device and biotechnology industries. Oxford PharmaGenesis won the Queen’s Award for Enterprise in 2015, the Corporate and Social Responsibility Prize at the 2016 Communique Awards, and in 2017 was named one of the Top 1000 Companies to Inspire Britain.